Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial - Lorusso, D; Mouret-Reynier, M A; Harter, P (Int J Gynecol Cancer, 2024)